146 related articles for article (PubMed ID: 3256109)
21. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
22. Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.
Pennisi MG; Lo Giudice S; Masucci M; De Majo M; Reale S; Vitale F
Vet Res Commun; 2008 Sep; 32 Suppl 1():S303-5. PubMed ID: 18683068
[No Abstract] [Full Text] [Related]
23. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
[TBL] [Abstract][Full Text] [Related]
24. Hair parasite load as a new biomarker for monitoring treatment response in canine leishmaniasis.
Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Morillas-Márquez F; Martín-Sánchez J
Vet Parasitol; 2016 Jun; 223():20-5. PubMed ID: 27198771
[TBL] [Abstract][Full Text] [Related]
25. Human visceral leishmaniasis and relationship with vector and canine control measures.
Costa DNCC; Bermudi PMM; Rodas LAC; Nunes CM; Hiramoto RM; Tolezano JE; Cipriano RS; Cardoso GCD; Codeço CT; Chiaravalloti Neto F
Rev Saude Publica; 2018 Nov; 52():92. PubMed ID: 30484481
[TBL] [Abstract][Full Text] [Related]
26. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino.
Neogy AB; Vouldoukis I; da Costa JM; Monjour L
Vet Parasitol; 1994 Sep; 54(4):367-73. PubMed ID: 7839561
[TBL] [Abstract][Full Text] [Related]
28. [Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis].
Deplazes P; Arnold P; Skaggs J; Gessler M
Schweiz Arch Tierheilkd; 1992; 134(2):85-93. PubMed ID: 1566026
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs.
Brandonisio O; Panunzio M; Faliero SM; Ceci L; Fasanella A; Puccini V
Vet Immunol Immunopathol; 1996 Sep; 53(1-2):95-103. PubMed ID: 8941972
[TBL] [Abstract][Full Text] [Related]
30. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis.
Guarga JL; Moreno J; Lucientes J; Gracia MJ; Peribáñez MA; Castillo JA
Vet Immunol Immunopathol; 2002 Sep; 88(1-2):13-20. PubMed ID: 12088640
[TBL] [Abstract][Full Text] [Related]
32. Leishmania infantum in a Central Italy dog shelter: retrospective study of serologic reactivity during a 4-year period in a confined dog population subjected to preventive and therapeutic treatment.
Podaliri Vulpiani M; Iannetti L; Di Mattia T; Dalla Villa P
Vet Parasitol; 2009 Mar; 160(3-4):190-7. PubMed ID: 19111991
[TBL] [Abstract][Full Text] [Related]
33. [Visceral leishmaniasis in Santarem/PA: general aspects of the control, serological survey in dogs and treatment of the human cases].
Senra MS; Pimentel PS; de Souza PE
Rev Bras Malariol Doencas Trop; 1985; 37():47-59. PubMed ID: 3843132
[No Abstract] [Full Text] [Related]
34. [Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
Bellido-Blasco JB; Arnedo-Pena A; Romeo-García MA; Herrero-Carot C
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):136-7. PubMed ID: 19254647
[No Abstract] [Full Text] [Related]
35. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
João A; Pereira MA; Cortes S; Santos-Gomes GM
J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
[TBL] [Abstract][Full Text] [Related]
36. [Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
Aoun K; Laamrani El Idrissi A; Harrat Z; Marty P
Bull Soc Pathol Exot; 2015 Aug; 108(3):229-30. PubMed ID: 26002086
[No Abstract] [Full Text] [Related]
37. The mass use of deltamethrin collars to control and prevent canine visceral leishmaniasis: A field effectiveness study in a highly endemic area.
Leite BMM; Solcà MDS; Santos LCS; Coelho LB; Amorim LDAF; Donato LE; Passos SMS; Almeida AO; Veras PST; Fraga DBM
PLoS Negl Trop Dis; 2018 May; 12(5):e0006496. PubMed ID: 29758031
[TBL] [Abstract][Full Text] [Related]
38. Culling dogs in scenarios of imperfect control: realistic impact on the prevalence of canine visceral leishmaniasis.
Costa DN; Codeço CT; Silva MA; Werneck GL
PLoS Negl Trop Dis; 2013; 7(8):e2355. PubMed ID: 23951375
[TBL] [Abstract][Full Text] [Related]
39. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
Aste G; Di Tommaso M; Steiner JM; Williams DA; Boari A
Vet Res Commun; 2005 Aug; 29 Suppl 2():269-72. PubMed ID: 16244972
[No Abstract] [Full Text] [Related]
40. Canine leishmaniasis.
Alvar J; Cañavate C; Molina R; Moreno J; Nieto J
Adv Parasitol; 2004; 57():1-88. PubMed ID: 15504537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
